Aclarion has been granted European patent EP3928695 titled "Magnetic Resonance Spectroscopy Pulse Sequence, Acquisition, And Processing System And Method (For Diagnosing Back Pain Such As Low Back Pain Associated With Degenerative Disc Disease)"
Portfolio Pulse from Benzinga Newsdesk
Aclarion has been granted European patent EP3928695 for a system and method using Magnetic Resonance Spectroscopy to diagnose back pain, including low back pain associated with Degenerative Disc Disease.
July 23, 2024 | 7:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aclarion has received a European patent for a system that uses Magnetic Resonance Spectroscopy to diagnose back pain, including low back pain associated with Degenerative Disc Disease.
The granting of the European patent is a significant milestone for Aclarion, potentially enhancing its market position and opening new revenue streams in the European market. This development is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100